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Bothrops spp envenomation and ischemic stroke have intricate pathogenesis. 
Local effects like edema, pain, redness, necrosis, and systemic manifestations 
such as coagulation disorders, thrombosis, renal failure, and hemorrhage are 
recognized. Thus, hemorrhagic stroke is a common neurological complication, 
neverthless ischemic stroke is poorly understood. A 50 years-old male, without 
comorbid illness, is referred from a rural area in southwestern Colombia due to 
Bothrops spp snakebite on the left hand. On admission, the patient presented 
deterioration of consciousness and required mechanical ventilation assistance. 
MRI is showed multiple ischemic areas in the bilateral frontal-temporal and 
occipital regions. Two months later, the patient with a favorable resolution, 
persists with central paresis in the III and VI cranial nerves and positive 
Babinski's sign. The pathophysiology of ischemic stroke due to snakebite is 
complex. Procoagulant activity of venom components, hypovolemic shock, 
endothelial damage, and thromboinflammation can explain ischemic stroke. 
Although ischemic stroke is rare, it should be considered as a complication of 
the ophidian accident caused by Bothrops spp. 








La mordedura de serpiente Bothrops spp y el ataque cerebrovascular 
isquémico (ACV) tienen una patogénesis compleja. Se reconocen efectos 
locales como edema, dolor, enrojecimiento, necrosis y manifestaciones 
sistémicas como trastornos de la coagulación, trombosis, insuficiencia renal y 
hemorragia, por lo que el accidente cerebrovascular hemorrágico es una 
complicación neurológica común, pero el accidente cerebrovascular isquémico 
es escasamente conocido. Paciente masculino de 50 años, sin enfermedad 
comorbilidades, remitido de una zona rural del suroccidente de Colombia 
debido a mordedura de serpiente Bothrops spp en la mano izquierda. Al 
ingreso, el paciente presentó deterioro de la conciencia y requirió asistencia 
ventilatoria mecánica. Se toma una resonancia magnética donde se observan 
múltiples áreas isquémicas en las regiones frontal-temporal y occipital 
bilaterales. Dos meses después, el paciente con resolución favorable persiste 
con paresia en los pares craneales III y VI y signo de Babinski positivo. La 
fisiopatología del accidente cerebrovascular isquémico por mordedura de 
serpiente es compleja. La actividad procoagulante de los componentes del 
veneno, el choque hipovolémico, el daño endotelial y la tromboinflamación 
pueden explicar el accidente cerebrovascular isquémico. Aunque el accidente 
cerebrovascular isquémico es raro, debe considerarse como una complicación 
del accidente ofídico causado por serpiente Bothrops spp. 
Palabras clave: accidente cerebrovascular; Bothrops; mordedura de serpiente; 
venenos de serpiente.  
 
 
Snake bite and cerebrovascular attack (CVA) is a complex event whose 
pathogenesis is not yet fully understood, and it is considered one of the most 
severe complications (1). Bothrops spp vipers belong to the Viperidae family, 
which comprises about 200 species of snakes. The Russell's viper (Daboia 
ruselli), Echis carinatus, Bitis arietans, Crotalus spp, Sistrurus spp, Bothrops 
spp, and Bothropoides spp are among the most notorious species for posing 
the greatest danger in humans. These snakes are mostly found in the 
Americas, Europe, Africa and Asia (2-4). 
Bothrops spp snakebites produce the majority of envenomations in Central and 
South America. In the Department of Nariño, located in the southwestern of 
Colombia, reports shows that the Bothrops snake (mainly Bothrops asper) 
caused 43.6% of ophidic accidents (5). The Bothrops spp viper is know for its 
intricate pathogenesis either due to its local effects such as edema, pain, 
redness, and necrosis, or due to systemic manifestations that are characterized 
by coagulation disorders, thrombosis, kidney failure and; especially 
hemorrhages (6). Although hemorrhagic stroke is a common neurologic 
complication (7-10), ischemic stroke is a very poorly understood phenomenon in 
pathogenesis. The toxic effects of venom in cerebrovascular event have been 
described in hemorrhagic stroke; however, it has been argued that the 
secondary procoagulant effect of various components of the poison, 
hypotensive shock and vasculitis mediated by the immune system is 
responsible for the ischemic stroke that leads to an unfavorable prognosis in 
most cases (1,7). This case report presents a 50-year-old patient with a 
massive ischemic stroke caused by Bothrops spp envenomation in a rural area 
in southwestern Colombia. 
Case report 
50 years-old male patient without medical history background. The patient was 
referred from a rural area in the southwestern of Colombia (department of 
Nariño), to the emergency room of our hospital. He consulted the emergency 
room for a Bothrops spp snakebite, on the second finger of the left hand. At the 
primary care hospital, the physical examination showed progression of edema 
to the left arm, without evidence of ulceration, hemorrhage, necrosis or signs of 
infection, or other findings. The following laboratory tests were performed: PT 
44 seconds, normal complete blood count, and normal kidney function. 
The patient was treated with 9 vials of polyvalent antivenom, 4 hours after was 
referred. He arrived at our hospital 13 hours after the snakebite, 
hemodynamically unstable, with deterioration of the level of consciousness, 
agitation and left hemiparesis which required management in the Intensive Care 
Unit (ICU) for mechanical ventilation assistance. During the paraclinical controls 
the blood test showed thrombocytopenia, dysfibrinogemia with fibrinogen levels 
less than 50 mg/ml, and clotting times without alterations. The patient was 
evaluated by neurologist, who orders brain magnetic resonance imaging (MRI) 
which revealed multiple ischemic areas in the bilateral frontal-temporal and 
bilateral occipital region and pons and cerebellum (figure 1). 
Due to the severity of the stroke, the administration of a new antivenom scheme 
is determined (each vial contains 10 mL of lyophilized equine polyvalent 
antivenom which neutralizes at least 25, 10 and 5 mg of the venom of the 
Bothrops asper/atrox, Crotalus and Lachesis snake). The patient did not receive 
plasma because this would had increased the procoagulant risk, and fibrinogen 
level increased gradually in the first 24 hours after the antivenom treatment. The 
patient showed gradual progressive improvement, in the follow-up control two 
months later. He presented bilateral VI and III paresis strength 2/5 left side, 
Babinski's sign positive left with a modified Rankin Scale (mRs) of 4. The cranial 
nerve involvement could be associated with cerebellar and pons infarction, as 
well as snakebite- associated ophthalmoplegia has also been described (11). 
The authors have in their possession the informed consent in which the patient 
declare to authorize the publication of the case and corresponding images. 
The present study complies with all the ethical regulations for research in 
humans, no intervention was carried out , and informed consent was obteined for 
its publication.  
The authors have in their possession the informed consent in which the patient 
declare to authorize the publication and the corresponding images. 
Discussion 
Snake bite and stroke is detailed in the literature. In the study by Mosquera et 
al. (7), it was found that there is a 2.6% prevalence of cerebrovascular 
complications among 309 victims of snakebites (7). Ischemic stroke has been 
described in other snake species, mainly in Gloydius brevicaudus, Crotalus 
durissus terrificus, Hypnale, Echis carinatus, and the Russell viper (12-22). 
A study conducted in Sri Lanka showed that of 500 patients who had been 
bitten by a Russell viper, 1.8% had complications with ischemic stroke (23). The 
studies carried out in Martinica provide a closer panorama about ischemic 
stroke, in which the pro-coagulant effects are specified, reaching up to 22% of 
thrombotic complications such as pulmonary thromboembolism, myocardial 
infarction and 12% of stroke in the patients observed (24-26). 
In Colombia, a study of 39 cases found that 12.8% of the patients who 
presented Bothrops snakebite had a hemorrhage in the central nervous system, 
but without reports of ischemic stroke (27). Furthermore, in four additional 
Colombian studies involving around 698 patients, ischemic stroke did not occur 
(28-31). To the authors knowledge and according to the literature review, 7 
cases of ischemic stroke due to the Bothrops spp envenomation have been 
documented (26,32-35) (table 1). In Colombia, this is not very detailed in the 
literature, and only some descriptions are found. Angarita et al., reported a 
stroke related to an ophidian accident (33), and Cañas et al., recently reported 
an ischemic stroke in the brainstem caused by the Bothrops atrox snake (35). 
Therefore, the present case is the third reported in Colombia and the eighth 
reported in the world. 
The etiopathogenesis of ischemic stroke remains to be fully elucidated (36,37). 
The most relevant hypothesis currently considered is thromboinflammation, 
which is activated by the different toxins of the venom. The most representative 
enzymes are metalloproteases and type-C lectins that are responsible for 
stimulating platelet function and pro-inflammatory activity (38), causing 
endothelial injury, stimulation of the immune system, immune-mediated 
vasculitis, hypercoagulable state and systemic hypotension (1,38). Other toxins 
such as digestive enzymes and complementary factors produce local and 
systemic injury. The most severe enzymes are zinc-dependent 
metalloproteinases called “hemorrhages”, which cause hemorrhage due to 
hydrolysis of the basal lamina in capillaries (39). Similarly, phospholipase A2 is 
involved in the formation of edema, myotoxicity, and anticoagulant effects. 
Additional studies of snake venom; in which proteomics is included, have 
revealed that some venom compounds are acid phospholipases A2, serine 
proteinases, acid 1-amino oxidases, zinc-dependent metalloproteinases, and 
specific C-type lectin binding molecules (40-42). 
The molecules release in the edema and hemorrhages it the metabolites of 
arachidonic acid (cyclooxygenase and lipoxygenase), bradykinin, histamine and 
serotonin (43). It has been shown that the Bothrops lanceolatus snake is the 
most associated with producing systemic thrombotic complications (26,44). 
Therefore, it is understood that toxins produce the thrombotic phenomenon 
through endothelial injury due to the direct action of the venom on the vessels 
(6). Endothelial damage is the result of the synergistic effect of 
metalloproteinase and phospholipase A2 (45). The hiperviscosity caused by the 
hypovolemic state and hypoperfusion secondary to hypotension contributes to 
the occlusion of the vessels (46). Similarly, some toxins promote the activation 
of the complement system through the generation of anaphylatoxins that 
hydrolyze C3 and C5, activating the three complement pathways, particularly, 
the lectin pathway and the inactivation of C1-INH, which is an important inhibitor 
of coagulation proteins contributing to inflammation and thrombosis (47). 
Factor V Leiden has also been considered since it plays a key role in the 
activation of the anticoagulant and procoagulant pathways, being activated by 
several toxins and proteases present in the venom of the vipers Vipera, Naja 
naja oxiana, and Bothrops atrox (48). In a comparative analysis of the coagulant 
activity of the venoms of the different Bothrops spp, the venom of B. 
erythromelas showed high levels of Factor X and prothrombin activators (49). 
The venoms possess thrombin activating enzymes derived from the snake 
Bothrops spp (50). The main molecules associated with the anticoagulant and 
procoagulant effect of the Bothrops snake are described below (table 2). 
Conclusion 
The pathogenesis of the Bothrops envenomation and the thrombotic 
phenomenon is complex There are numerous theories that attempt its 
mechanism; therefore, further research is required to advance its 
understanding. The thromboinflammation theory explains some of the local and 
systemic effects such as thrombocytopenia, prolonged clotting times, 
disseminated intravascular coagulation, and thrombotic events. Procoagulant 
activity, hypovolemic shock, and endothelial injury has been considered to 
promote ischemic stroke. In this case report, even with early initiation of 
treatment, a catastrophic ischemic stroke occurred that led to considerable 
disability of the patient. It is imperative to understand this phenomenon as a 
severe neurological complication in American countries such as Colombia, 
where the Bothrops snake is widely distributed and ophidian accidents are a 
frequent reason for consultation in the emergency room. 
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Figure 1. MRI (DWI) showing multiple areas of frontotemporal, bilateral occipital 
and cerebellar ischemia. 
 
Source: Archive of the Department of Diagnostic Images, Departmental 
University Hospital of Nariño, Pasto. Colombia.  





COUNTRY SNAKEBITE  VASCULAR 
TERRITORY 
LABORATORY TESTS ON 
ADMISSION  
DEFICIT 
1 Numeric et al., 
(2002) (26).  
Martinica B. caribbaeus Right ACA, and multiple 
small foci in cerebellar 
cortex, right PCA, both 
MCA 
CK 1212 U/L, (26–174) 
CRP 147.7 mg/L, (0–10).  
PTT 29 sec (control: 32), 
fibrinogen 6.33 g/L( 2–4),  
 D dimer positive.  
PLT 201000 
Left hemiplegia and a partial 
Wernicke’s aphasia 
2 Angarita et al., 
(2003) (33) 
Colombia B. spp Right MCA, Left MCA PT > 2 min, PTT>2min, 
PLT 23500 
ocular deviation to the right, 
dysarthria, left hemiparesis, bilateral 
Babinski  
3 Merle et al., 
(2005) (32).  
Martinica B. lanceol 
 
atus 
Right PCA PLT 52,000 cells/mm3 
 PT 14% (70–100%),  
aPTT 51 sec. (normal 32), 
fibrinogen  < 0.5 g/L ( 2–4 
g/L), factor II level  66% 
(70–120%), factor V level 
17% (70–120%), FDP  
2,560 µg/ml (normal <5 
g/mL) 
left, lateral, homonymous 
quadranopsia with macular 
epargne.  
4 Thomas et al., 
(2006) (34). 
Martinica B. lanceolatus.  Both PCA PLT 57000,Fibrinogen<0,5, 
PT 34 sec, aPTT 51 sec, 
FDP 2560 µg/ml, CRP 
1,9mg/ml 
right hemiparesis and aphasia 
5 Thomas et al., 
(2006) (34).  
Martinica B. lanceolatus Left  MCA  
 
PLT 20000,Fibrinogen 
2,45, PT 15 sec, aPTT 35 
sec, FDP 320µg/ml, CRP 
25,3 mg/ml 
right hemiparesis and aphasia 
6 Thomas et al., 
(2006) (34).  
Martinica B. lanceolatus Both PCA 
 left MCA 
PLT 260000,Fibrinogen 
2,81 PT 13 sec, aPTT 28 
sec, CRP 0 mg/ml 
left hemiparesis and left 
homonymous 
hemianopsia. 
7 Cañas et al.  
(2016) (35).  
Colombia  B. atrox Basilar  artery PLT 18.000/mm3,  
PT >1 min  
Comatose, miotic pupils without 
reaction to 
A PTT >1 min fibrinogen 
was not detected.  
 
light and generalized hypotonia, 
lack of response of limbs to painful 
stimuli bilateral Babinski  
 
8 Martinez-Villota 
et al.  
Colombia  Bothrops. spp MCA TP 44 sec, blood test 
normal, function liver and 
renal normal, fibrinogen < 
50 mg/ml.  
impaired level of consciousness, 
agitation and left hemiparesis  
Abbreviators: Prothrombin time (PT) Partial thromboplastin time (PTT), acPTT: activated cephalin time or partial thromboplastin time, PLT: platelet, CK: 
Creatine kinase, CRP: C-reactive protein, anterior cerebral artery (ACA), middle cerebral artery (MCA), posterior cerebral arteries (PCA), FDP: Fibrin 
degradation product.  











Table 2.   Main procoagulant and anticoagulant molecules of the hemostatic system of the Bothrops snake. 
ANTICOAGULANTS FACTORS  PROCOAGULANTS FACTORS  
 a.  THROMBOINFLAMMATION (38).  
a. ASPERCITIN, HEMORRHAGES, 
METALLOPROTEINASES: These substances 
can cause thrombocytopenia, prolongation PT 
and PTT, disseminated intravascular 
coagulation, they produce hemorrhages of the 
cerebral parenchymal and subarachnoid (7).    
IMMUNE SYSTEM: 
- Activation of the function and migration of 
the leucocytes.  
- Release of pro-inflammatory mediators 
(IL-1β, IL-6, IL-8, TNF-α, MIP-1α, NO, 
histamine, serotonin, PAF, bradykinin, 
PGE2, TXA2, LTB4, y RANTES). 
- Generation of anaphylatoxins (C3 and 
C5).  
 - Generation of DAMPs, TF, and Factor 
Wv. 
HEMOSTATIC SYSTEM:   
- Expression of procoagulant molecules (PT activators, 
thrombin agonist enzymes, factor X and V activators).  
 - Expression of pro-thrombotic and pro-fibrinolytic 
molecules (Factor Wv, TF, fibrinogen, C5 and C3) that 
interact with the platelet surface.   
 - Activation of platelet receptors (PAR-1, PAR-4, GPIb-IX-
V, GPVI, TLR2 and TLR4). 
- Activation of platelets by SV-CLRPs of a non-enzymatic 
pathway by interaction of toxins with the CLEC-2 receptor. 
b. ACTIVATION OF C-PROTEIN: Through of 
the activation of the serine proteases.    
b. BATROXOBIN: It is a serine protease similar to the thrombin of Bothrops atrox moojeni with the ability 
to coagulate fibrinogen. Thrombin that releases fibrinopeptides A and B from the NH2 terminal domains of 
fibrinogen Aα and Bβ chains respectively. Batroxabine only releases fibrinopeptide A. Thus, batroxobin 
binds fibrin in a different way than thrombin, which may contribute to its higher affinity interaction, selective 
fibrinopeptide A release, and prothrombotic properties. (51).     
c. INHIBITION OF FACTOR IX AND X.  c. BOTROCETIN: It is a heterodimeric protein snake venom isolated in Bothrops jararaca that induces 
VWF and platelet glycoprotein GPIb-dependent platelet agglutination (52).  
d. INHIBITION OF THE TROMBIN:  Through the 
Bothrojaracine.  
d. BASPARIN A: It was isolated from the venom of Bothrops asper; it does not induce local tissue 
alterations such as hemorrhage, myonecrosis, and edema. Nevertheless, it does not induce systemic 
hemorrhage, thrombocytopenia, or prolongation of the bleeding time following intravenous administration. 
At low doses, the only observed effect induced by Basparin A, when injected intravenously or 
intramuscularly into mice is defibrinogenation. At higher doses, intravenous administration resulted in 
sudden death due to numerous occlusive thrombi in the pulmonary vessels (53). 
e. INHIBITION OF THE COMPLEX 
PROTHROMBINASE: Action through of the 
phospholipase A2.    
e. ASPERCITIN, HEMORRHAGES, and METALLOPROTEINASES: The cause of injury to the blood 
vessels wall. Produce cerebral infarct (7).  
f. FIBRINOLYTIC ACTIVITY: Adamalysin, 
fibrolase, atroxase, lebetase.  
 
 
f. COMPLEMENT SYSTEM: Activation of the 3 complement pathways, especially the lectin-C pathway 
through the hydrolysis of peptides C3, C4, and C5. The venom also acts directly on the C5a fragment for 
the generation of C5a convertase. The C1 inhibitor is a serine protease that regulates the complement 
cascade (inhibits C1r, C1s and MASPs), and the coagulation cascade acting on fibrinolytic proteins 
(kallikrein, FXIIa, FXIa, and plasmin)  (46).     
g. PLATELET AGREGATION INHIBITORS: α-
fibrinogenase, phospholipase A2, 5'-
nucleotidases, jarahagin, catrocollastatin, 
crovidisin, disintegrins, cerastatin, barbourin, 
albolabrin, cistrin, flavoviridine, elegantin, 
rhodostatin, tigramine  (53).  
g. PLATELET AGGREGATION ACTIVATORS: thrombocytin, cerastocytin, cerastobine, convuloxin, 
aggregoserpentin, trimucitin, agretin, bitiscentin, alboagregins, tocaracetin, flavocetins (54).  
Abbreviators: PGE2: prostaglandins; TXA2: thromboxane; LTB4: leukotrienes; C3 and C5: complement fragments; DAMPs: molecular patterns associated with 
damage; TF: tissue factor; vW: von Willebrand factor; PAR-1, PAR-4: protease activating receptors; GPIb-IX-V: GPIb-IX-V glycoprotein complex; GPIV: 
glycoprotein VI; TLR2 and TLR4: toll-like receptors; CLEC-2: C-type lectin receptor 
Source: The authors. 
Figure 1. Flow-diagram of the pathophysiology in the Bothrops envenomation.  
 
 
Source: The authors.  
